Top Tweets for #NASHsummit
Media activities:
➡️ Reimbursement list!
➡️ #Hepatitis B & C elimination
➡️ #LiverCancer #EUCancerPlan
➡️ Opening of #LiverCentar
➡️ #Donation medical devices and medicines for children.
➡️ #NASHSummit 23
➡️ More in the next days, it's coming!!! #FattyLiverMonth #EUCancerPlan
Experts estimate that about 20% of people with #FattyLiver will progress to NASH
NASH is closely related to obesity and diabetes, but its symptoms are often silent or non-specific, making it difficult to diagnose @loucas_fourlas
#FattyLiverMonth #NASHday #NASHsummit #LiverTwitter
NaSH内で一年で一つサービスを出すことがノルマになりました。
これをNaSHの伝統にしていきたいと思います！
#NaSHSummit
What will it take to achieve the first approved therapeutic for #NASH? Our Chief Development Officer, Leigh MacConell, will share her insights into establishing achievable endpoints in #clinicaltrials at the #NASHSummit tomorrow. https://t.co/o73K7w3o0I #livertwitter
We are honored to have our scientists Banu Cole and Ryan Feaver share how our REVEAL-Tx platform has generated a model to identify and validate new targets at #NASHSummit
At the #NASHSummit, Dr. @karsdal will explain how collagen biomarkers can be used to identify patients with high disease activity and who are therefore more prone to fibrosis progression, and how they can distinguish between liver and cardiovascular events.
#research #pharma
Rebecca Taub, MD, Director, Founder, CMO & President, R&D of Madrigal, will participate in a panel discussion & deliver a presentation on NASH drug development at the 5th Annual #NASHSummit on Nov. 30, 2021.
Learn more at https://t.co/UKLKY8odEQ
#LiverTwitter #LiverDisease
Join me today at 5 pm EST at #NASHSummit as I will present key data from @LiverSaver's SUNN-1 (Screening for Undiagnosed #NAFLD #NASH) study & discuss why we believe the decision to not address the threat of health posed by asymptomatic #NASH early can no longer be justified.
What do SUNN-1, SUNN-SCREEN & SUNN-2 have in common? Join our CEO @WayneEskridge1 at #NASHSummit tomorrow as he will review key data from FLF's study on screening for undiagnosed #NAFLD #NASH in real-life settings & discuss future plans for SUNN programs👉https://t.co/tSB08WHmAz
Check out our #NASHSummit Partner booths @OlinkProteomics @SiemensHealth @cerbaresearch @HepQuant @jacksonlab #Genuityscience #CATOsms @crownbioscience @InfiCureBio @physiogenex @DiaPharma @AragenBio @AESGlobal1 https://t.co/txCTFVfhvX
Deepa Rajagopalan, VP of New Products, is participating in a panel discussion at the virtual #NASHSummit focused on advancing combination therapies. Learn more: https://t.co/xBvoqm5oyO
Are you attending the #NASHSummit? We look forward to connecting & exploring ways to integrate patient centricity into your #NASH diagnostics & drug development programs.
Join us on Dec 17 at 5 pm EST for @WayneEskridge1's presentation on screening for undiagnosed #NAFLD NASH.
Will you be at the Virtual #NASHSummit? Join us and our partner, @OWLMetabolomics, tomorrow at 2 pm EST for our presentation on Tracking Fibrosis Stages Through Metabolomics in NASH!
Our CSO, Pablo Ortiz, takes part tomorrow in the international event #NASHSummit.
He leads the online speech "Tracking Fibrosis Stages Through Metabolomics in NASH".
Discover the full program 👉 https://t.co/aCZjY6ZPJv
#OWL #biotech #innovación #LifeScience
We're LIVE! Thrilled to be at the #NashSummit with @capigian of @MTSU and Aaron Steiner @aaronsteiner of @CommutersTrust as we get fired up to present for "The Third Wave of Public Transportation, a Data Driven Incentive Based Approach to Public Mobility" #NAS2020 #DataScience
Last day at the 3rd #NASHSummit in #London where I had the honor and pleasure to represent the @GlobalLiver Institute and meet some outstanding people like Frank Anania from the #Gastroenterology Division of the #FDA . #LivingBurgundy #OctoberIs4Livers @EASLnews @AASLDtweets
Excellent presentation on the competitive #clinicaltrials landscape in #NASH during the 3rd #NASHSummit in #London. @GlobalLiver @pgtraber
Amazing 3rd #NASHSummit and meetings here in #London. Paving the way for the 2020 #NASHDay @GlobalLiver
Today’s the day! Dr Marc Goldfinger is speaking at #NASHSummit Europe. He will be discussing the use of multiparametric MRI as a non-invasive biomarker for #NASH. If you’re attending, the talk is from 14:10 – 14:30, don’t miss it.
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.3M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.8M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.7M followers
KATY PERRY
@katyperry
87.2M followers
Taylor Swift
@taylorswift13
81.1M followers
Lady Gaga
@ladygaga
72.6M followers
Kim Kardashian
@kimkardashian
69.6M followers
Virat Kohli
@imvkohli
69.2M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.6M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
61.9M followers
CNN
@cnn
61.9M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.3M followers